Summary
The Cigna Group (CI) has filed an 8-K report detailing the departure of Eric P. Palmer, Executive Vice President for Enterprise Strategy and President and Chief Executive Officer of Evernorth Health Services. Mr. Palmer's employment officially concludes on April 26, 2025. The filing outlines the terms of his separation agreement, which includes a cash payment of $5.2 million and continued vesting and payout of equity awards valued at approximately $4.8 million. This agreement is structured in accordance with the Company's existing Executive Severance Benefits Plan and Long-Term Incentive Plan.
Key Highlights
- 1Eric P. Palmer, a key executive, will depart The Cigna Group on April 26, 2025.
- 2Palmer's separation agreement includes a cash payment of $5.2 million.
- 3The cash payment reflects 78 weeks of base pay, a prorated 2025 EIP target, and 150% of his 2025 EIP target.
- 4Equity awards (stock options, restricted stock, SPSs) valued at approximately $4.8 million will continue to vest and be paid out based on actual performance.
- 5A COBRA subsidy for 18 months is also part of the separation package.
- 6Certain stock options will expire earlier than their original dates, with specific provisions for options granted before and after 2021.
Frequently Asked Questions
The direct financial impact detailed in this filing includes a cash payment of $5.2 million and an estimated $4.8 million in continued equity vesting and payouts. This totals approximately $10 million in compensation and benefits associated with his departure.
Mr. Palmer will receive a cash payment of $5.2 million, which includes severance based on his base pay, a significant portion of his 2025 incentive target, and a prorated amount for the portion of 2025 he worked. He will also receive an 18-month COBRA subsidy and continued vesting/payouts for his equity awards based on performance, with specific terms for stock option expirations.
The continued vesting and payout of equity awards, valued at approximately $4.8 million, suggests that while Mr. Palmer is leaving, the company is fulfilling its contractual obligations tied to performance. Investors should monitor the actual performance metrics used for these payouts, as they could indicate the company's overall performance during the vesting periods.
Yes, the agreement includes customary confidentiality, non-solicitation, non-competition, and non-disparagement provisions. These clauses are designed to protect Cigna's business interests after Mr. Palmer's departure.